Malgorzata Lukawska-Wasowska

Staroscinska St
Warsaw, MZ 02516, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Lipophilicity profiling of anthracycline antibiotics by microemulsion electrokinetic chromatography-effects on cardiotoxicity and endotheliotoxicity.

Lipophilicity profiling of anthracycline antibiotics by microemulsion electrokinetic chromatography-effects on cardiotoxicity and endotheliotoxicity.

Journal: Electrophoresis
Published: July 15, 2019

Chemical modification of melphalan as a key to improving treatment of haematological malignancies.

Chemical modification of melphalan as a key to improving treatment of haematological malignancies.

Journal: Scientific reports
Published: June 14, 2019

Antileukemic activity of novel adenosine derivatives.

Antileukemic activity of novel adenosine derivatives.

Journal: Scientific reports
Published: January 21, 2019

Erratum to "Molecular mechanism of action of oxazolinoanthracyclines in cells derived from human solid tumors. Part 2" [Toxicol. in Vitro 46 (2018) 323-334].

Erratum to "Molecular mechanism of action of oxazolinoanthracyclines in cells derived from human solid tumors. Part 2" [Toxicol. in Vitro 46 (2018) 323-334].

Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: February 13, 2018

Novel oxazolinoanthracyclines as tumor cell growth inhibitors-Contribution of autophagy and apoptosis in solid tumor cells death.

Novel oxazolinoanthracyclines as tumor cell growth inhibitors-Contribution of autophagy and apoptosis in solid tumor cells death.

Journal: PloS one
Published: January 30, 2018

In Vitro Antileukemic Activity of Formamidine Epidoxorubicin Analogs.

In Vitro Antileukemic Activity of Formamidine Epidoxorubicin Analogs.

Journal: Anticancer research
Published: August 19, 2017

Molecular mechanism of action of oxazolinoanthracyclines in cells derived from human solid tumors. Part 2.

Molecular mechanism of action of oxazolinoanthracyclines in cells derived from human solid tumors. Part 2.

Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: June 11, 2017

Effects of structural modification of the daunosamine moiety of anthracycline antibiotics on pKa values determined by capillary zone electrophoresis.

Effects of structural modification of the daunosamine moiety of anthracycline antibiotics on pKa values determined by capillary zone electrophoresis.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: January 11, 2017

Histological Subtype of Ovarian Cancer as a Determinant of Sensitivity to Formamidine Derivatives of Doxorubicin - in Vitro Comparative Studies with SKOV-3 and ES-2 Cancer Cell Lines.

Histological Subtype of Ovarian Cancer as a Determinant of Sensitivity to Formamidine Derivatives of Doxorubicin - in Vitro Comparative Studies with SKOV-3 and ES-2 Cancer Cell Lines.

Journal: Asian Pacific journal of cancer prevention : APJCP
Published: November 01, 2016

Identification of the key pathway of oxazolinoanthracyclines mechanism of action in cells derived from human solid tumors.

Identification of the key pathway of oxazolinoanthracyclines mechanism of action in cells derived from human solid tumors.

Journal: Toxicology and applied pharmacology
Published: July 19, 2016

Spectroscopic studies of anthracyclines: Structural characterization and in vitro tracking.

Spectroscopic studies of anthracyclines: Structural characterization and in vitro tracking.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: April 16, 2016

Formamidinodoxorubicins are more potent than doxorubicin as apoptosis inducers in human breast cancer cells.

Formamidinodoxorubicins are more potent than doxorubicin as apoptosis inducers in human breast cancer cells.

Journal: Anticancer research
Published: April 12, 2015
Showing 1-12 of 21

Last Updated: 09/26/2026